Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature

Clinical Rheumatology

Volumn 36, Issue 3, 2017, Pages 583-590

  Giuggioli, Dilia ^a   Colaci, M ^a   Cassone, G ^a   Fallahi, P ^a,b   Lumetti, F ^a   Spinella, A ^a   Campomori, F ^a   Manfredi, A ^a   Manzini, C U ^a   Antonelli, A ^a,b   Ferri, C ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Autoimmunity; Hypovitaminosis D; Scleroderma; Systemic sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CENTROMERE ANTIBODY; COLECALCIFEROL; CREATININE; LIOTHYRONINE; PARATHYROID HORMONE; PHOSPHORUS; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROXINE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CALCINOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGED; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; SCLERODERMA, SYSTEMIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85008627044     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3535-z     Document Type: Article

References (45)

1. Ferri C, Sebastiani M, Lo Monaco A et al (2014) Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimm Rev 13:1026–1034
2. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME (2011) Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 10:276–281
3. Holick MF. Vitamin D deficiency (2007) N Engl J Med 357:266–281.
4. Peterlik M, Boonen S, Cross HS, Lamberg-Allardt C (2009) Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int. J. Environ. Res Public Health 6:2585–2607
5. Kamen DL, Tangpricha V (2010) Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 88:441–450
6. Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimm Rev 12:127–136
7. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y (2013) Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 45:256–266
8. Wöbke TK, Sorg BL, Steinhilber D (2014) Vitamin D in inflammatory diseases. Front Physiol 5:244
9. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149
10. Amital H, Szekanecz Z, Szucs G et al (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69:1155–1157
11. Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9:507–510
12. Cutolo M (2009) Vitamin D and autoimmune rheumatic diseases. Rheumatology 48:210–212
13. Serup J, Hagdrup H (1985) Vitamin D metabolites in generalized scleroderma. Evidence of a normal cutaneous and intestinal supply with vitamin D. Acta Derm Venereol 65:343–345
14. Matsuoka LY, Dannenberg MJ, Wortsman J, Hollis BW, Jimenez SA, Varga J (1991) Cutaneous vitamin D3 formation in progressive systemic sclerosis. J Rheumatol 18:1196–1198
15. Orbach H, Zandman-Goddard G, Amital H et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385–400
16. Braun-Moscovici Y, Furst DE, Markovits D et al (2008) Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol 35:2201–2205
17. Dovio A, Data V, Carignola R et al (2008) Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol 35:2206–2213
18. Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36:1924–1929
19. Rios FR, Fernandez RC, Callejas Rubio JL, Ortego CN (2010) Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain. J Rheumatol 37:1355
20. Caramaschi P, Dalla GA, Ruzzenente O et al (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 12:1419–1425
21. Arnson Y, Amital H, Agmon-Levin N et al (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10:490–494
22. Ibn Yacoub Y, Amine B, Laatiris A, Wafki F, Znat F, Hajjaj-Hassouni N (2012) Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int 32:3143–3148
23. Seriolo B, Molfetta L, Cutolo M (2011) Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin Rheumatol 30:445–446
24. Belloli L, Ughi N, Marasini B (2011) Vitamin D in systemic sclerosis. Clin Rheumatol 30:145–146
25. Gambichler T, Chrobok I, Höxtermann S, Kreuter A (2011) Significantly decreased serum 25-hydroxyvitamin d levels in a large German systemic sclerosis cohort. J Rheumatol 38:2492–2493
26. Shinjo SK, Bonfá E, de Falco CV, Pereira RM (2011) Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatol Int 31:1075–1080
27. Rios-Fernández R, Callejas-Rubio JL, Fernández-Roldán C et al (2012) Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions. Clin Exp Rheumatol 30:905–911
28. Atteritano M, Sorbara S, Bagnato G et al (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8:e66991
29. Corrado A, Colia R, Mele A et al (2015) Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) vitamin D serum levels in systemic sclerosis. PLoS One 10:e0137912
30. Zhang L, Duan Y, Zhang TP et al (2015) Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int J Rheum Dis doi. doi:10.1111/1756-185X.12794
31. Montabone E, Data V, Carignola R (2016) Vitamin D status and quality of life in systemic sclerosis patients. J Clin Rheumatol 22:229–230
32. Sampaio-Barros MM, Takayama L, Sampaio-Barros PD, Bonfá E, Pereira RM (2016) Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings. Rev Bras Reumatol 56:337–344
33. van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747
34. Holick MF, Binkley NC, Bischoff-Ferrari HA, Endocrine Society et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
35. Lippi G, Nouvenne A, Ticinesi A, Bonelli P, Salvagno GL, Cervellin G, Guidi GC (2015) The burden of vitamin D deficiency in a Mediterranean country without a policy of food fortification. Acta Biomed 86:59–62
36. Carmel NN, Rotman-Pikielny P, Lavrov A, Levy Y (2015) Vitamin D antibodies in systemic sclerosis patients: findings and clinical correlations. Isr Med Assoc J 17:80–84
37. Wiersinga WM (2016) Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol Metab 31:213–222
38. Toubi E, Shoenfeld Y (2010) The role of vitamin D in regulating immune responses. Isr Med Assoc J 12:174–175
39. Schoindre Y, Benveniste O, Costedoat-Chalumeau N (2013) Vitamin D and autoimmunity. Press Med 42:1358–1363
40. van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101
41. Artaza JN, Norris KC (2009) Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200:207–221
42. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28
43. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J (2010) Vitamin D inhibition of pro-fibrotic effects on transforming growth factor β1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 118:142–150
44. Willis BC, Liebler JM, Luby-Phelps K et al (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321–1332
45. van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO (2004) 1alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23:233–239